To further test the hypothesis that miRNA-related SNPs involved in the LAMB3-miR-218 pathway contribute to cervical cancer risk, we performed a case–control study with a much larger sample size to validate the reported associations with cervical cancer risk in Eastern Chinese women. The gene discussed is LAMB3; the disease is cervical cancer.